New York, New York, United States Related Funds
Funds with similar focus
| Fund Name | Location |
| Ascendas CNTrade Group | Central, Central Region, Singapore |
| Context Ventures | District of Columbia, United States, Washington |
| Crescent Capital Partners | Australia, New South Wales, Sydney |
| Environmental Data Resources | Connecticut, Shelton, United States |
| eumo | Japan, Tokyo |
| Green Rock | Brazil, São Paulo, Sao Paulo |
| ITC Service Group | California, Citrus Heights, United States |
| Jinjiang Capital | Changzhou, China, Zhejiang |
| Juroku Bank | Gifu, Gifu Prefecture, Japan |
| Massa Innovations | England, London, United Kingdom |
| NBT (Next Big Thing) | England, London, United Kingdom |
| NextAI | Canada, Ontario, Toronto |
| Raystone Capital | Beijing, Beijing, China |
| Terra | Seoul, Seoul-t'ukpyolsi, South Korea |
| The Ledger Group | Canada, Ontario, Toronto |
| Zhangjiang Science & Technology Investment Corporation | China, Hunan, Zhangjiang |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Endpoint Health | $52M | 02 Jun 2022 | Palo Alto, California, United States | ||
Ansa Biotechnologies | $68M | 11 Apr 2022 | Berkeley, California, United States | ||
Finless Foods | $34M | 02 Mar 2022 | Berkeley, California, United States | ||
HAYA Therapeutics | $5M | 09 Feb 2022 | Lausanne, Vaud, Switzerland | ||
Cellino Biotech | $80M | 25 Jan 2022 | Cambridge, Massachusetts, United States | ||
Compound Foods | $4M | 07 Sep 2021 | San Francisco, California, United States | ||
Compound Foods | $4M | 31 Aug 2021 | San Francisco, California, United States | ||
Debut Biotech | $22M | 12 Aug 2021 | San Diego, California, United States | ||
Mission Barns | $24M | 07 Apr 2021 | Berkeley, California, United States |
– Compound Foods is a synthetic biology company that creates coffee without coffee beans.
– The company raised $4.5m in seed funding.
– Backers include Chris Sacca’s climate fund Lowercarbon Capital, SVLC, Humboldt Fund, Collaborative Fund, Maple VC, Petri Bio and angel investors like Nick Green, CEO of Thrive Market.
– Debut Biotech is a San Diego, CA-based developer of a biomanufacturing platform harnessing cell-free enzymes.
– The company raised $22.6m in Series A funding.
– The round was led by Material Impact with participation from Cultivian Sandbox Ventures, Fine Structure Ventures, ACVC Ventures, Humboldt Fund, Cantos Ventures, as well as existing investors including KdT Ventures.
– The new capital will be used to commercialize ingredients developed from its proprietary cell-free biomanufacturing platform.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Endpoint Health | $52M | 02 Jun 2022 | Palo Alto, California, United States | ||
Ansa Biotechnologies | $68M | 11 Apr 2022 | Berkeley, California, United States | ||
Finless Foods | $34M | 02 Mar 2022 | Berkeley, California, United States | ||
HAYA Therapeutics | $5M | 09 Feb 2022 | Lausanne, Vaud, Switzerland | ||
Cellino Biotech | $80M | 25 Jan 2022 | Cambridge, Massachusetts, United States | ||
Compound Foods | $4M | 07 Sep 2021 | San Francisco, California, United States | ||
Compound Foods | $4M | 31 Aug 2021 | San Francisco, California, United States | ||
Debut Biotech | $22M | 12 Aug 2021 | San Diego, California, United States | ||
Mission Barns | $24M | 07 Apr 2021 | Berkeley, California, United States |
